The UH software will help DrillDocs customers make better and safer decisions out on the rigs. Photo via Getty Images

A Houston startup has tapped into the know-how of three University of Houston professors to help improve oil and gas drilling operations.

The startup, DrillDocs, has licensed software developed by UH professors Jiefu Chen, Xuqing (Jason) Wu, and Zhu Han that enables real-time analysis of activity at onshore and offshore drilling rigs. Specifically, the software examines video to help classify the volume of cuttings from the shale-shaker components of drilling equipment.

According to the American Association of Petroleum Geologists, cuttings are small pieces of rock that are chipped away by a bit while a well is being drilled. The fragments then travel from the bit to the surface of the water, where they can be "caught" and studied. Drill cuttings often yield the only rock data gained from a well.

"Cutting analysis is an important task for an efficient, low-cost, and risk-free drilling execution," Chen says in a UH news release.

According to the news release, the UH software will study the cutting data to help DrillDocs customers "make more informed drilling decisions, reduce safety and environmental risks, and improve drilling performance and production."

Drilling technicians usually must repeatedly study cuttings manually, which can stifle progress and lead to human errors, according to UH.

Calvin Holt and Francois Ruel co-founded DrillDocs in 2020. The bootstrapped startup is developing the CleanSight system, which monitors shale-shaker components in an effort to reduce drilling costs and risks. DrillDocs' surface-based computer vision system can deliver data via laptops, smartphones, and other devices about the size, shape, and quantity of rocks floating to the surface.

In March, DrillDocs was identified as one of the four most promising startups that participated in a CERAWeek pitch competition.

"We're taking computer vision to the drilling rig," Holt, CEO of DrillDocs, said during his pitch. "Now, for the first time, drilling and geomechanics teams will have unique, real-time data to ascertain the well's condition."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.